drugset / Trial / NCT00390065

Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely

NCT00390065

Phase 4 Completed 108 enrolled Maternite Regionale Universitaire
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

Utilization of nitric oxide (NO) therapy has been related to a trend towards short term improvement in very premature infants. A two year follow-up of children treated soon after birth with NO in the neonatal period, suggests that a significant improvement in neurodevelopmental outcome might occur. This study aims to evaluate follow-up at 6 years, in respiratory and neurodevelopmental outcome, of children born very prematurely, some of them having been treated with nitric oxide in the neonatal period.

Timeline

Start
2006-10
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 5 ppm Inhaled

Indications

No indication recorded.